CDPHE updates COVID-19 quarantine and isolation guidance to align with CDC
CDPHE updates COVID-19 quarantine and isolation guidance to align with CDC STATEWIDE (Dec. 27, 2021) — Today, the Colorado Department of Public Health and Environment updated guidance to match new…
Key Guidelines for Gradual Dosage Reductions of Psychotropic Medications – Caring for the Ages
https://www.caringfortheages.com/article/S1526-4114(21)00441-8/fulltext#relatedArticles Find the low-hanging fruit: look for low doses. An order such as “Quetiapine 25 mg QHS” (every night at bedtime) is a red flag that this medication is being…
Omicron Multiplies Faster in Airways, Slower in Lungs
https://www.medscape.com/viewarticle/964911 Compared to the earlier Delta variant, Omicron multiplies itself 70 times more quickly in airway passages, which may facilitate person-to-person spread, they said. But in lung tissues, Omicron replicates…
Rapid Increase of Omicron Variant Infections in the United States: Management of Healthcare Personnel with SARS-CoV-2 Infection or Exposure
CDC Recs 12/24/21 https://emergency.cdc.gov/han/2021/pdf/CDC_HAN_460.pdf https://drive.google.com/file/d/1QmABN_IRNw-repndD-1NpvBCtoOxx3wW/view?usp=sharing Healthcare personnel with higher-risk exposure • Personnel who have received all COVID-19 vaccine and booster doses as recommended by CDC. Under conventional strategies, asymptomatic healthcare…
Early U.K. Data: Two Vax Doses Don’t Cut It Against Omicron | MedPage Today
https://www.medpagetoday.com/special-reports/exclusives/96172
Paxlovid Approved
Paxlovid EUA Approved Today!! — (nirmatrelvir co-packaged with ritonavir) PAXLOVID may only be used by healthcare providers to treat mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age…
FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID
https://www.fda.gov/media/155050/download Paxlovid EUA Approved !! — (nirmatrelvir co-packaged with ritonavir) PAXLOVID may only be used by healthcare providers to treat mild-to-moderate COVID-19 in adults and pediatric patients (12 years of…
EUA 105 Pfizer Paxlovid LOA (12222021)
PAXLOVID may only be used by healthcare providers to treat mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive…
It’s Okay for Docs to Refuse to Treat Unvaccinated Patients
https://www.medscape.com/viewarticle/958434?sso=true&impID=3886713&uac=17637FN&src=wnl_tp10f_211219_mscpedit